NCT05740046 is a NA clinical trial of INTORUS in Down Syndrome, sponsored by University of Extremadura.

Who is sponsoring NCT05740046?

NCT05740046 is sponsored by University of Extremadura.

What drugs are being tested in NCT05740046?

Interventions in NCT05740046: INTORUS.

What condition does NCT05740046 study?

NCT05740046 studies Down Syndrome.

Is NCT05740046 still recruiting?

NCT05740046 is currently completed. Last updated 1 December 2023.

Last reviewed 2023-12-01 · How we verify

NCT05740046

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motor Intervention Whit the Intorus Tool on Children With Down Syndrome

Completed NA Last updated 1 December 2023

What this trial tests

NA trial testing INTORUS in Down Syndrome in 30 participants. Completed in 31 July 2023.

Timeline

1 February 2023

Primary endpoint
30 June 2023

31 July 2023

Quick facts

Lead sponsor	University of Extremadura
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	30
Start date	1 February 2023
Primary completion	30 June 2023
Estimated completion	31 July 2023
Sites	1 location across Spain

Drugs / interventions tested

INTORUS

Conditions studied

Down Syndrome — all drugs for Down Syndrome →

Sponsor

University of Extremadura

Who can join

Adults 4 to 18, any sex, with Down Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test in people with down syndrome how does the INTORUS tool influence their psychomotor development. The main question it aims to answer is: \- Does the INTORUS tool improve psychomotor development in people with Down Syndrome? The intervention program will be carried out during the Functional Habilitation sessions and will be carried out by the center's professionals. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the user attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs. Each session will consist of several exercises with their corresponding rest breaks described in the Intervention Protocol. Each session attendance will be recorded following an attendance record model created for the occasion. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the psychomotor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the psychomotor level with the INTORUS device. Randomization will be carried out using the Oxford Minimization and Randomization software.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of INTORUS

Trials testing the same drug.

NCT05778994 — Use of Intorus to Control Anxiety Before Exams in Students at the University of Extremadura · NA · completed
NCT05753800 — Efficacy of INTORUS as a Therapeutic Tool in Motor Intervention in Patients at Aspace Centres in the Province of Cáceres · NA · completed

Other recruiting trials for Down Syndrome

Currently open trials in the same condition.

NCT07416201 — Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy · recruiting
NCT07484464 — Effects of the Otago Exercise Program on Balance, Endurance, and Motor Coordination in Children With Down Syndrome · NA · recruiting
NCT07428863 — Effects of Jump Rope on Navicular Drop in Down Syndrome · NA · recruiting
NCT07260136 — Cervical Spine Abnormalities in Down Syndrome · active not recruiting
NCT07248449 — Physical Fitness in DS: A Comparison of Cuevas Medak and Rebound Exercises · NA · recruiting

Other University of Extremadura trials

Trials by the same sponsor.

NCT07292311 — Reliability of Muscle Strength and Activation Assessment Tools and Effects of an Online Therapeutic Exercise Program in · NA · active not recruiting
NCT07408986 — Reference Values and Reliability of Handgrip Strength Assessment Using a Digital Dynamometer in Healthy Adolescents and · completed
NCT07427329 — Benefits of Physical Activity During the School Day to Reduce Mental Fatigue and Optimize Cognitive and Psychosocial Pro · NA · active not recruiting
NCT06953401 — Muscle Activity of the Gastrocnemius and Soleus Muscles by Surface Electromyography. · not yet recruiting
NCT06976593 — Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05740046 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Extremadura
Last refreshed: 1 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05740046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing